↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

132 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   13 valent conjugated pneumococcal vaccine   -   -   -   -   1件:
265 
 2   150 mg gsk1265744b   -   -   -   -   1件:
265 
 3   300mg gemcabene   Gemcabene   -   -   -   1件:
265 
 4   600mg gemcabene   Gemcabene   -   -   -   1件:
265 
 5   [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate   Acetate   -   -   -   1件:
265 
 6   Abacavir   Abacavir   D00891, D07057   -   -   3件:
135,
265,
325 
 7   Abacavir 300mg twice daily   Abacavir   D00891, D07057   -   -   1件:
265 
 8   Abacavir sulfate   Abacavir   D00891, D07057   -   -   1件:
265 
 9   Abacavir sulfate, lamivudine and zidovudine   Lamivudine, Zidovudine   D00353, D00413   -   -   1件:
265 
 10   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 11   Acetyl- l- carnitine   Levocarnitine   D02030, D02176, D04713   -   -   1件:
265 
 12   Acetylcarnitine   Acetylcarnitine   -   -   -   2件:
2,
265 
 13   Acipimox   Acipimox   D07190   -   -   2件:
78,
265 
 14   Akcea-angptl3-lrx   -   -   -   -   2件:
79,
265 
 15   Amprenavir   Amprenavir   D00894   -   -   1件:
265 
 16   Aramchol   Aramchol   -   -   -   1件:
265 
 17   Atazanavir   Atazanavir   D01276, D07471   -   -   1件:
265 
 18   Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis)   Atazanavir   D01276, D07471   -   -   1件:
265 
 19   Atazanavir (reyataz)   Atazanavir   D01276, D07471   -   -   1件:
265 
 20   Atazanavir/ritonavir   Atazanavir   D01276, D07471   -   -   1件:
265 
 21   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 22   Atorvastatin calcium   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
265 
 23   Avandia administration for 6-12 weeks   -   -   -   -   1件:
265 
 24   Azt/3tc   -   -   -   -   1件:
265 
 25   Baricitinib   Baricitinib   D10308   2件: JAK1, JAK2   32件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   8件:
41,
46,
49,
50,
93,
107,
265,
325 
 26   Bms-232632   Atazanavir   D01276, D07471   -   -   1件:
265 
 27   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 28   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 29   Cd-4 guided therapy interruption   -   -   -   -   1件:
265 
 30   Cholic acid   Cholic acid   D10699   1件: NR1H4   1件: Bile secretion   4件:
20,
234,
265,
310 
 31   Cofactor supplementation (thiamine, riboflavin, l-carnitine)   Riboflavin   D00050, D01622, D01913   -   -   1件:
265 
 32   Combivir   Zidovudine   D00413   -   -   1件:
265 
 33   Combivir (zidovudine [azt] / lamivudine [3tc])   Lamivudine, Zidovudine   D00353, D00413   -   -   1件:
265 
 34   Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis)   -   -   -   -   1件:
265 
 35   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 36   Didanosine   Didanosine   D00296   -   -   2件:
25,
265 
 37   Different haart regimens   -   -   -   -   1件:
265 
 38   Diosmin   Diosmin   D07858   -   -   1件:
265 
 39   Diosminex, 500 mg, tabletki powlekane   -   -   -   -   1件:
265 
 40   Efavirenz   Efavirenz   D00896   -   -   1件:
265 
 41   Efavirenz (efv)   Efavirenz   D00896   -   -   1件:
265 
 42   Emtricitabine   Emtricitabine   D01199   -   -   4件:
25,
93,
265,
325 
 43   Emtricitabine/tenofovir   Emtricitabine   D01199   -   -   1件:
265 
 44   Enfuvirtide   Enfuvirtide   D02499   -   -   2件:
25,
265 
 45   Enfuvirtide (t20)   Enfuvirtide   D02499   -   -   1件:
265 
 46   Fenofibrate   Fenofibrate   D00565   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   5件:
8,
79,
93,
94,
265 
 47   Gemcabene   Gemcabene   -   -   -   2件:
79,
265 
 48   Genotropin (human recombinant growth hormone)   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
265 
 49   Glycerine   Glycerin   D00028   -   -   1件:
265 
 50   Growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   11件:
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 51   Growth hormone releasing hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
265 
 52   Gsk1265744b (sodium salt) containing 14c-gsk1265744b   -   -   -   -   1件:
265 
 53   Hu leptin (a-100)   Leptin   -   -   -   1件:
265 
 54   Human growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
78,
193,
265 
 55   Human recombinant leptin (metreleptin)   Metreleptin   D05014   1件: LEPR   6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease (NAFLD)   1件:
265 
 56   Indinavir   Indinavir   D00897, D02861, D03833   -   -   1件:
265 
 57   Isis 304801   Volanesorsen   D11648   1件: APOC3   2件: Cholesterol metabolism, PPAR signaling pathway   1件:
265 
 58   Kaletra (lopinavir [lpvr])   Lopinavir   D01425   -   -   1件:
265 
 59   L-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   6件:
13,
96,
97,
265,
298,
316 
 60   L-lactic acid   Lactic acid   D00111   -   -   1件:
265 
 61   Lactic acid   Lactic acid   D00111   -   -   2件:
265,
299 
 62   Lamivudine   Lamivudine   D00353   -   -   6件:
26,
42,
46,
135,
265,
325 
 63   Lamivudine/zidovudine   Lamivudine, Zidovudine   D00353, D00413   -   -   1件:
265 
 64   Leptin   Leptin   -   -   -   2件:
6,
265 
 65   Lopinavir   Lopinavir   D01425   -   -   2件:
130,
265 
 66   Lopinavir/ritonavir   Lopinavir, Ritonavir   D00427, D01425   -   -   1件:
265 
 67   Lopinavir/ritonavir + nevirapine   Nevirapine   D00435   -   -   1件:
265 
 68   Lopinavir/ritonavir + zidovudine + lamivudine   Lamivudine, Zidovudine   D00353, D00413   -   -   1件:
265 
 69   Mecasermin   Mecasermin   D03297, D04870   2件: GHR, IGF1R   33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway   5件:
78,
96,
168,
265,
299 
 70   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 71   Metformin hydrochloride   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   3件:
81,
158,
265 
 72   Metreleptin   Metreleptin   D05014   1件: LEPR   6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease (NAFLD)   1件:
265 
 73   Metrelpetin   -   -   -   -   1件:
265 
 74   Myalept   Metreleptin   D05014   1件: LEPR   6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease (NAFLD)   1件:
265 
 75   Nelfinavir   Nelfinavir   D00899, D08259   -   -   3件:
49,
265,
331 
 76   Nelfinavir mesylate   Nelfinavir   D00899, D08259   -   -   1件:
265 
 77   Nevirapine   Nevirapine   D00435   -   -   1件:
265 
 78   Niacin   Niacin   D00049   -   -   3件:
6,
78,
265 
 79   Non-nucleoside reverse transcriptase inhibitors   -   -   -   -   1件:
265 
 80   Norvir   Ritonavir   D00427   -   -   2件:
265,
299 
 81   Nucleomaxx   -   -   -   -   1件:
265 
 82   Nucleoside analogue sparing haart regimen   -   -   -   -   1件:
265 
 83   Nucleoside reverse transcriptase inhibitors   -   -   -   -   1件:
265 
 84   Obeticholic acid   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   3件:
93,
265,
296 
 85   Perform blood cells and fibroblasts biochemical and immuno-labeled investigations   -   -   -   -   1件:
265 
 86   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 87   Pioglitazone or metformin   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
265 
 88   Pneumococcal polysaccharide vaccine 23 valent   -   -   -   -   1件:
265 
 89   Pravastatin   Pravastatin   D00893, D08410   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
13,
46,
49,
67,
79,
96,
164,
265,
333 
 90   Pravastatin sodium   Pravastatin   D00893, D08410   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
265 
 91   Protease inhibitor   -   -   -   -   1件:
265 
 92   Protease inhibitors   -   -   -   -   1件:
265 
 93   R-methuleptin   Metreleptin   D05014   1件: LEPR   6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease (NAFLD)   1件:
265 
 94   Raltegravir   Raltegravir   D06676   -   -   4件:
13,
26,
93,
265 
 95   Recombinant human growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
78,
193,
265 
 96   Recombinant human growth hormone + rosiglitazone   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
265 
 97   Reyataz   Atazanavir   D01276, D07471   -   -   1件:
265 
 98   Riboflavin   Riboflavin   D00050, D01622, D01913   -   -   8件:
13,
38,
46,
96,
97,
162,
168,
265 
 99   Ritonavir   Ritonavir   D00427   -   -   4件:
2,
86,
130,
265 
 100   Ritonavir (norvir)   Ritonavir   D00427   -   -   1件:
265 
 101   Rosiglitazone   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   5件:
46,
75,
97,
222,
265 
 102   Rosiglitazone maleate   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   3件:
46,
75,
265 
 103   Saquinavir   Saquinavir   D00429, D01160   -   -   2件:
86,
265 
 104   Serostim®[somatropin (rdna origin) for injection]   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
265 
 105   Setmelanotide   Setmelanotide   -   -   -   2件:
202,
265 
 106   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 107   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 108   St200   -   -   -   -   1件:
265 
 109   Standard continuous antiretroviral therapy   -   -   -   -   1件:
265 
 110   Stavudine   Stavudine   D00445   -   -   1件:
265 
 111   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 112   Sustiva   Efavirenz   D00896   -   -   1件:
265 
 113   Tat4 gel concentration a   -   -   -   -   1件:
265 
 114   Tat4 gel concentration b   -   -   -   -   1件:
265 
 115   Tenofovir   Tenofovir   D06074   -   -   5件:
2,
25,
93,
265,
325 
 116   Tenofovir df   Tenofovir   D06074   -   -   1件:
265 
 117   Tenofovir disoproxil   Tenofovir disoproxil   D01982   -   -   2件:
93,
265 
 118   Tenofovir disoproxil fumarate   Tenofovir disoproxil   D01982   -   -   1件:
265 
 119   Tesamorelin   Tesamorelin   D06655, D09015   1件: GHRHR   2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction   2件:
78,
265 
 120   Tesamorelin (egrifta)   Tesamorelin   D06655, D09015   1件: GHRHR   2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction   1件:
265 
 121   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   7件:
1,
2,
3,
13,
78,
113,
265 
 122   Th9507   -   -   -   -   1件:
265 
 123   Thiamine   Thiamine   D08580   -   -   2件:
13,
265 
 124   Tipranavir   Tipranavir   D03843, D08605   -   -   1件:
265 
 125   Total dietary replacement   -   -   -   -   1件:
265 
 126   Truvada   Tenofovir disoproxil   D01982   -   -   1件:
265 
 127   Use of lipid-lowering drugs.   -   -   -   -   1件:
265 
 128   Viracept versus sustiva with stavudine and epivir   Stavudine   D00445   -   -   1件:
265 
 129   Viral load driven treatment interruption   -   -   -   -   1件:
265 
 130   Volanesorsen   Volanesorsen   D11648   1件: APOC3   2件: Cholesterol metabolism, PPAR signaling pathway   1件:
265 
 131   Volanesorsen sodium, apoc-iii antisense oligonucleotide   Volanesorsen   D11648   1件: APOC3   2件: Cholesterol metabolism, PPAR signaling pathway   1件:
265 
 132   Zidovudine   Zidovudine   D00413   -   -   6件:
25,
26,
135,
265,
325,
331 

先頭へ